🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India flag India · Delayed Price · Currency is INR
1,202.00
-2.20 (-0.18%)
Nov 18, 2026, 3:28 PM IST

Zydus Lifesciences Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
303,781271,484232,415195,474172,374151,099
Revenue Growth
24.02%16.81%18.90%13.40%14.08%4.90%
Cost of Revenue
84,37875,23665,38463,93764,70756,857
Gross Profit
219,403196,248167,031131,537107,66794,242
Selling, General & Admin
71,57064,71150,00142,45437,64832,472
Other Operating Expenses
75,41159,08848,26436,04734,26329,873
Operating Expenses
167,142137,999107,42986,14579,13969,501
Operating Income
52,26158,24959,60245,39228,52824,741
Interest Expense
-5,220-3,650-935-440-1,255-1,144
Interest & Investment Income
4,2374,2371,8621,281768696
Earnings From Equity Investments
1,2289715781,184946462
Currency Exchange Gain (Loss)
10,02812,8051,6348062,8431,482
Other Non Operating Income (Expenses)
-2285131-11251622
EBT Excluding Unusual Items
62,30672,66362,77248,21232,08126,859
Merger & Restructuring Charges
-1,058-245--177-101-
Impairment of Goodwill
---1,350--5,941-
Gain (Loss) on Sale of Investments
2922925901,385596874
Gain (Loss) on Sale of Assets
2323345134208-17
Asset Writedown
---846---
Legal Settlements
-3,066-3,975----
Other Unusual Items
-1,875-1,576-666-281-1,127
Pretax Income
56,99867,18260,84549,27326,84328,843
Income Tax Expense
13,99715,94714,1199,7755,8785,117
Earnings From Continuing Operations
43,00151,23546,72639,49820,96523,726
Earnings From Discontinued Operations
---230-4622,457
Net Income to Company
43,00151,23546,72639,72820,91946,183
Minority Interest in Earnings
-1,019-835-1,471-1,133-1,316-1,310
Net Income
41,98250,40045,25538,59519,60344,873
Net Income to Common
41,98250,40045,25538,59519,60344,873
Net Income Growth
-14.67%11.37%17.26%96.88%-56.31%110.32%
Shares Outstanding (Basic)
1,0041,0061,0061,0121,0161,024
Shares Outstanding (Diluted)
1,0041,0061,0061,0121,0161,024
Shares Change
-0.25%--0.56%-0.37%-0.79%-
EPS (Basic)
41.8350.0944.9738.1419.3043.83
EPS (Diluted)
41.8350.0944.9738.1419.3043.83
EPS Growth
-14.45%11.37%17.92%97.61%-55.97%110.32%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
2,705-12,77450,87422,89716,5799,019
Free Cash Flow Per Share
2.69-12.7050.5622.6316.328.81
Dividend Per Share
-1.00011.0003.0006.0002.500
Dividend Growth
--90.91%266.67%-50.00%140.00%-28.57%
Gross Margin
72.22%72.29%71.87%67.29%62.46%62.37%
Operating Margin
17.20%21.46%25.64%23.22%16.55%16.37%
Profit Margin
13.82%18.57%19.47%19.74%11.37%29.70%
Free Cash Flow Margin
0.89%-4.71%21.89%11.71%9.62%5.97%
EBITDA
71,61971,64668,30352,57235,34431,695
EBITDA Margin
23.58%26.39%29.39%26.90%20.50%20.98%
D&A For EBITDA
19,35813,3978,7017,1806,8166,954
EBIT
52,26158,24959,60245,39228,52824,741
EBIT Margin
17.20%21.46%25.64%23.22%16.55%16.37%
Effective Tax Rate
24.56%23.74%23.21%19.84%21.90%17.74%
Revenue as Reported
308,597276,579235,110198,315174,240153,346
Advertising Expenses
-6,0963,3682,9572,5732,514